SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions

Neuro-Oncology

Volumn 5, Issue 4, 2003, Pages 244-254

  Vadlamuri, Satya V ^a   Media, J ^a   Sankey, Steadman S ^a   Nakeff, Alexander ^a   Divine, George ^a   Rempel, Sandra A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COLLAGEN; FIBRONECTIN; HYALURONIC ACID; LAMININ; OSTEONECTIN; PLASTIC; SCLEROPROTEIN; TENASCIN; VITRONECTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DENSITY; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE VESSEL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GLIOMA CELL; GROWTH CURVE; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; WESTERN BLOTTING;

EID: 0142092638     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1093/neuonc/5.4.244     Document Type: Article

References (29)

1. Akiyama, Y., Jung, S., Salhia, B., Lee, S., Hubbard, S., Taylor, M., Mainprize, T., Akaishi, K., van Furth, W., and Rutka, J.T. (2001) Hyaluronate receptors mediating glioma cell migration and proliferation. J. Neurooncol. 53, 115-127.
2. Axisa, B., Loftus, I.M., Naylor, A.R., Goodall, S., Jones, L., Bell, P.R., and Thompson, M.M. (2002) Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques. Stroke 33, 2858-2864.
3. Bornstein, P., and Sage, E.H. (2002) Matricellular proteins: Extracellular modulators of cell function. Curr. Opin. Cell Biol. 14, 608-616.
4. Bradshaw, A.D., Francki, A., Motamed, K., Howe, C., and Sage, E.H. (1999) Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol. Biol. Cell 10, 1569-1579.
5. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88, 2648-2652.
6. Funk, S.E., and Sage, E.H. (1993) Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J. Cell. Physiol. 154, 53-63.
7. Gladson, C.L. (1999) The extracellular matrix of gliomas: Modulation of cell function. J. Neuropathol. Exp. Neurol. 58, 1029-1040.
8. Golembieski, W.A., and Rempel, S.A. (2002) cDNA array analysis of SPARC-modulated changes in glioma gene expression. J. Neurooncol. 60, 213-226.
9. Golembieski, W.A., Ge, S., Nelson, K., Mikkelsen, T., and Rempel, S.A. (1999) Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int. J. Dev. Neurosci. 17, 463-472.
10. Greenwood, J.A., and Murphy-Ullrich, J.E. (1998) Signaling of de-adhesion in cellular regulation and motility. Microsc. Res. Tech. 43, 420-432.
11. Hasselaar, P., and Sage, E.H. (1992) SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J. Cell. Biochem. 49, 272-283.
12. Kamihagi, K., Katayama, M., Ouchi, R., and Kato, I. (1994) Osteonectin/SPARC regulates cellular secretion rates of fibronectin and laminin extracellular matrix proteins. Biochem. Biophys. Res. Commun. 200, 423-428.
13. Kupprion, C., Motamed, K., and Sage E.H. (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273, 29635-29640.
14. Lamparter, S., Slight, S.H., and Weber, K.T. (2002) Doxycycline and tissue repair in rats. J. Lab. Clin. Med. 139, 295-302.
15. Lane, T.F., Iruela-Arispe, M.L., and Sage, E.H. (1992) Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J. Biol. Chem. 267, 16736-16745.
16. Mayer, U., Aumailley, M., Mann, K., Timpl, R., and Engel, J. (1991) Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur. J. Biochem. 198, 141-150.
17. Menon, P.M., Gutierrez, J.A., and Rempel, S.A. (2000) A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: High SPARC secretion correlates with decreased migration on vitronectin. Int. J. Oncol. 17, 683-693.
18. Murphy-Ullrich, J.E. (2001) The de-adhesive activity of matricellular proteins: Is intermediate cell adhesion an adaptive state? J. Clin. Invest. 107, 785-790.
19. NIH. National Institutes of Health. (2003) NIH Image. Available at http://rsb.info.nih.gov/nih-image/about.html, accessed June 27, 2003.
20. Pichler, R.H., Bassuk, J.A., Hugo, C., Reed, M.J., Eng, E., Gordon, K.L., Pippin, J., Alpers, C.E., Couser, W.G., Sage, E.H., and Johnson, R.J. (1996) SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated mesangial cell proliferation in vitro. Am. J. Pathol. 148, 1153-1167.
21. Raines, E.W., Lane, T.F., Iruele-Arispe, M.L., Ross, R., and Sage, E.H. (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. USA 89, 1281-1285.
22. Rempel, S.A., Golembieski, W.A., Ge, S., Lemke, N., Elisevich, K., Mikkelsen, T., and Gutiérrez, J.A. (1998) SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J. Neuropathol. Exp. Neurol. 57, 1112-1121.
23. Rempel, S.A., Golembieski, W.A., Fisher, J.L., Maile, M., and Nakeff, A. (2001) SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J. Neurooncol. 53, 149-160.
24. Rosenblatt, S., Bassuk, J.A., Alpers, C.E., Sage, E.H., Timpl, R., and Preissner, K.T. (1997) Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: Characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem. J. 324, 311-319.
25. Sage, E.H., and Bornstein, P. (1991) Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J. Biol. Chem. 266, 14831-14834.
26. 2+-binding EF-hand sequence. J. Cell Biochem. 57, 127-140.
27. Sasaki, T., Gohring, W., Mann, K., Maurer, F., Hohenester, E., Knauper, V., Murphy, G., and Timpl, R. (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J. Biol. Chem. 272, 9237-9243.
28. Schultz, C., Lemke, N., Ge, S., Golembieski, W.A., and Rempel S.A. (2002) Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res. 62, 6270-6277.
29. Uitto, V.J., Firth, J.D., Nip, L., and Golub, L.M. (1994). Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann. N.Y. Acad. Sci. 732, 140-151.